查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552870

神經診斷市場規模、佔有率、趨勢分析報告：按技術、最終用途、地區、細分市場預測，2024-2030 年

Neurodiagnostics Market Size, Share & Trends Analysis Report By Technology (Neuroimaging Technologies, In Vitro Diagnostics, Neuroinformatics), By End Use (Hospitals & Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

神經診斷市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球神經診斷市場規模預計將達到229.9億美元，2024年至2030年複合年成長率為3.8%。

推動市場成長的主要因素是由於人口變化和對其管理意識的提高而導致神經系統疾病盛行率的增加。此外，持續的技術改進加上對新型診斷技術日益成長的偏好將進一步刺激市場。神經系統疾病給社會和政府帶來了極其沉重的經濟負擔，全球整體約有 10 億人遭受痛苦。

在神經影像技術中，電腦斷層掃描佔據最大的市場佔有率，其次是磁振造影造影（MRI）。電腦斷層掃描 (CT) 使用電離輻射來創建影像，而 MRI 使用磁場中的無線電波。神經影像技術用於檢測腦損傷、腦區域發育畸形以及可能導致中風和癲癇的血管異常。

生物標記在神經系統疾病的體外診斷中發揮重要作用，其開發旨在利用神經系統資訊對疾病進行早期診斷。生物標記不可商業購買，其使用僅限於臨床研究環境。例如， Tau蛋白的 ELISA 檢測可用於阿茲海默症的臨床研究。此外，神經資訊學是研究神經科學和資訊科技的領域。這種整合使得以資料庫的形式儲存神經資料成為可能。預計神經資訊學市場在預測期內將以第二高的成長率成長。

神經診斷市場報告亮點

  • 由於預期壽命的延長，世界各地的老齡化人口正在增加。阿茲海默症和帕金森氏症等與老化相關的神經系統疾病的盛行率正在增加。這些疾病的診斷包括神經影像學、體外診斷和神經資訊學。
  • CT 和 MRI 是全世界最常使用的診斷影像技術，主要用於檢測腦部異常。
  • 神經生物標記在為診斷研究提供方向方面前景廣闊。目前，市場上還沒有商業化的生物標記，但正在進行廣泛的臨床研究以尋找生物標記的完美組合。
  • 2023年，北美佔據主要市場佔有率約35.8%，並將在預測期內保持領先地位。同時，亞太地區在預測期內的複合年成長率將高達 4.5%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章神經診斷市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 神經診斷市場分析工具
    • 波特的分析
    • PESTEL分析

第4章神經診斷市場：技術估計與趨勢分析

  • 細分儀表板
  • 神經診斷市場：2023 年和 2030 年技術變化分析
  • 神經影像技術
  • 體外診斷
  • 資訊科學

第5章神經診斷市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 神經診斷市場：最終用途變異分析，2023 年和 2030 年
  • 醫院和診所
  • 診斷實驗室
  • 形像中心市場
  • 其他

第6章 神經診斷市場：區域估計與趨勢分析

  • 2023 年及 2030 年神經診斷市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Canon Medical Systems Corporation
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Thermo Fisher Scientific, Inc.
    • FUJIFILM Corporation
    • Natus Medical Incorporated（Natus）
    • Lifelines Neuro
    • Advanced Brain Monitoring, Inc.
    • NIHON KOHDEN CORPORATION.
    • F. Hoffmann-La Roche Ltd
    • GE HealthCare.
    • Mitsar Co. LTD.
簡介目錄
Product Code: GVR-1-68038-277-8

Neurodiagnostics Market Growth & Trends:

The global neurodiagnostics market size is expected to reach USD 22.99 billion by 2030 ,registering a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Key factors driving the market growth include increasing prevalence of neurological diseases due to demographic changes and growing awareness of their management. In addition, consistent technological modifications coupled with increased preference for novel diagnostic technologies will further fuel the market. The economic burden of neurological diseases is extremely high on society and governments with around 1 billion people suffering globally.

Among all the neuroimaging techniques, computed tomography has the largest market share followed by Magnetic Resonance Imaging (MRI). Computed Tomography (CT) uses ionized radiations for the purpose of creating images, whereas MRI uses radio waves in a magnetic field. Neuroimaging techniques are used to detect brain injuries, developmental malformations in the brain area, vascular irregularities that may lead to stroke, epilepsy, etc.

Biomarkers are an important part of in vitro diagnostics for neurological disorders as their development is targeted at the early disease diagnosis with information about the nervous system. Although biomarkers are not commercially available in the market, their use is confined to clinical research settings. For instance, ELISA tests for Tau protein are available in clinical studies of Alzheimer's disease. In addition, neuroinformatics is a field that studies neuroscience and information technology. This integration allows the storage of neurological data in the form of databases. The neuroinformatics market is expected to grow at the second-highest growth rate during the forecast period.

Neurodiagnostics Market Report Highlights:

  • Increased life expectancy has resulted in an increased geriatric population across the globe. The prevalence of aging-related neurological diseases such as Alzheimer's disease and Parkinson's disease is on the rise. The diagnosis of these diseases includes neuroimaging, in vitro diagnosis, and neuroinformatics.
  • CT and MRI are the most commonly used imaging techniques across the globe, which are mainly used to detect brain abnormalities.
  • Neurological biomarkers are extremely promising as they provide a direction to the diagnostic studies. Although currently, no commercial biomarker is available in the market, extensive clinical research is happening to find out the perfect combinations of the biomarkers.
  • North America held the major market share of around 35.8% in 2023 and will retain its top position during the forecast period. On the other hand, Asia Pacific will exhibit the highest CAGR of 4.5% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurodiagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Neurodiagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Neurodiagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurodiagnostics Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Neuroimaging Technologies
    • 4.3.1. Neuroimaging Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Computed Tomography (CT)
      • 4.3.2.1. Computed Tomography (CT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Magnetic Resonance Imaging (MRI)
      • 4.3.3.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Nuclear Medicine Imaging (PET, SPECT)
      • 4.3.4.1. Nuclear Medicine Imaging (PET, SPECT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Near infrared spectroscopic imaging (NIRS)
      • 4.3.5.1. Near infrared spectroscopic imaging (NIRS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. Electro-encephalography (EEG)
      • 4.3.6.1. Electro-encephalography (EEG) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.7. Magneto-encephalography (MEG)
      • 4.3.7.1. Magneto-encephalography (MEG) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.8. Voxel based morphometry (VBM)
      • 4.3.8.1. Voxel based morphometry (VBM) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. In Vitro Diagnostics
    • 4.4.1. In Vitro Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Neuroinformatics
    • 4.5.1. Neuroinformatics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurodiagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurodiagnostics Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Hospitals and Clinics
    • 5.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Diagnostic Laboratories
    • 5.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Imaging Centers Market
    • 5.5.1. Imaging Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurodiagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Neurodiagnostics Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Neurodiagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Canon Medical Systems Corporation
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Siemens Healthineers AG
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Koninklijke Philips N.V.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. FUJIFILM Corporation
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Natus Medical Incorporated (Natus)
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Lifelines Neuro
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Advanced Brain Monitoring, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. NIHON KOHDEN CORPORATION.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. F. Hoffmann-La Roche Ltd
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. GE HealthCare.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. Mitsar Co. LTD.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives